Biomics & Chemics Consultancy
ActiveSummary
Biomics & Chemics Consultancy has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€59,565) and a net result of -€14,840. Equity has been shrinking by about 85% per year since 2019. Its solvency ranks better than 5% of 11,772 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is 0.7% (low).
Overview
Official details
Source: KBO- Status
- Active since 14-06-2018 Normal situation
- Activity
- Other technical testing and analysis NACE 71209and 4 others
- Establishment unit
- 2.278.233.456 9090 Merelbeke-Melle, since 14-06-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 19-12-2024
Board and ownership
- Coopman FrankDirector
- Maene PeterDirector
- HOLBIGENETICS54.22%· score 962025 annual accounts of HOLBIGENETICS
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.7%
- Gross margin
- -€9,581
- ▼ 12.1%
- Loss
- €14,840
- ▲ 22.1%
- Equity
- -€59,565
- ▼ 33.2%
- Total assets
- €39,187
- ▲ 250%
- Negative equity on 31-12-2025
Score breakdownraises riskCapped at 59: negative equityNegative equity -€59,565Loss of €14,840, the second in a row (financial year 2025)lowers riskSize: total assets €39,187Sector: Architectural and engineering activities; technical testing and analysis (NACE 71)Show the evidence
Checked score
About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 71, micro). It does better than 3% of them on solvency, 5% on liquidity, 4% on profitability and 15% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 6 days before the deadline. In the sector (NACE 71), the median for financial year 2024 was 8 days before the deadline, and 34% of those companies filed late.
Searched, nothing found (2)
Key points
- Risk: Negative equitydebts exceed assets in financial year 2025 -€59,565 View
- Risk: 7 loss-making years in a rowloss in financial year 2025 -€14,840 View
- Caution: Lower solvency than 95% of companies in architecture and engineeringsector median 53.9% · 11,772 companies -152.0% View
- Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View
Recent changes
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as Biomics & Chemics Consultancy: other technical testing and analysis (NACE 71209). They are comparable in size and age: total assets between €21,300 and €65,200, founded between 2018 and 2022.
| Company | Total assets | Gross margin |
|---|---|---|
| Biomics & Chemics Consultancy Merelbeke-Melle | €39,187 | -€9,581 |
| NORMADEX Comblain-au-Pont | €33,304 | -€6,444 |
| MVP Consultancy Schilde | €58,840 | -€18,436 |
| ACTAEON Beernem | €33,077 | -€4,115 |
| J’eau Solutions & Academy Sint-Niklaas | €29,084 | €859 |
| NO2COVID Geel | €65,178 | €1,218 |
| SENTADVICE Oostkamp | €21,313 | -€18,444 |
Key facts about Biomics & Chemics Consultancy
- What is the company number of Biomics & Chemics Consultancy?
- The company number of Biomics & Chemics Consultancy is 0697.909.555. The VAT number is the same number with BE in front: BE 0697.909.555.
- Where is Biomics & Chemics Consultancy based?
- The registered office is at Lammeke 15, 9090 Merelbeke-Melle.Company details
- What does Biomics & Chemics Consultancy do?
- According to the KBO register, the main activity is other technical testing and analysis (NACE 71209).
- What is the legal form of Biomics & Chemics Consultancy?
- The legal form of Biomics & Chemics Consultancy is Private limited company (BV).
- When was Biomics & Chemics Consultancy founded?
- Biomics & Chemics Consultancy was founded on 14-06-2018.
- Is Biomics & Chemics Consultancy still active?
- Yes, Biomics & Chemics Consultancy is an active enterprise in the KBO register.
- What is the turnover of Biomics & Chemics Consultancy?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is Biomics & Chemics Consultancy profitable?
- In financial year 2025, Biomics & Chemics Consultancy made a loss of €14,840.
- Where can I find the annual accounts of Biomics & Chemics Consultancy?
- Biomics & Chemics Consultancy filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Biomics & Chemics Consultancy due?
- Biomics & Chemics Consultancy must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.